Literature DB >> 10170937

Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA)--HCFA. Final rule with comment period.

.   

Abstract

This final rule revises regulations applicable to laboratories and implements provisions of the Clinical Laboratory Improvement Amendments of 1988 (CLIA), Public Law 100-578. The regulation applies to laboratories that examine human specimens for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of the health of, human beings. They specify the performance requirements, based on 19 test complexity and risk factors related to erroneous test results, that apply to laboratories that are subject to CLIA. They also list requirements for laboratories performing certain limited testing to be eligible for a certificate of waiver. These laboratories will not be inspected routinely, nor will they be required to meet certain other CLIA requirements.

Entities:  

Mesh:

Year:  1992        PMID: 10170937

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  41 in total

Review 1.  Validation of laboratory-developed molecular assays for infectious diseases.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  mHealth spectroscopy of blood hemoglobin with spectral super-resolution.

Authors:  Sang Mok Park; Michelle A Visbal-Onufrak; Md Munirul Haque; Martin C Were; Violet Naanyu; Md Kamrul Hasan; Young L Kim
Journal:  Optica       Date:  2020-06-20       Impact factor: 11.104

3.  Comparing exponentially weighted moving average and run rules in process control of semiquantitative immunogenicity immunoassays.

Authors:  Troy E Barger; Lei Zhou; Michael Hale; Michael Moxness; Steven J Swanson; Narendra Chirmule
Journal:  AAPS J       Date:  2009-12-10       Impact factor: 4.009

4.  Quality leadership and quality control.

Authors:  Tony Badrick
Journal:  Clin Biochem Rev       Date:  2003-08

5.  Pilot studies for proficiency testing using fluorescence in situ hybridization with chromosome-specific DNA probes: a College of American Pathologists/American College of Medical Genetics Program.

Authors:  G W Dewald; A R Brothman; M G Butler; L D Cooley; S R Patil; I A Saikevych; N R Schneider
Journal:  Arch Pathol Lab Med       Date:  1997-04       Impact factor: 5.534

6.  The Importance of Epitope Density in Selecting a Sensitive Positive IHC Control.

Authors:  Kodela Vani; Seshi R Sompuram; Anika K Schaedle; Anuradha Balasubramanian; Monika Pilichowska; Stephen Naber; Jeffrey D Goldsmith; Kueikwun G Chang; Farzad Noubary; Steven A Bogen
Journal:  J Histochem Cytochem       Date:  2017-06-30       Impact factor: 2.479

7.  Evaluation of direct-to-consumer low-volume lab tests in healthy adults.

Authors:  Brian A Kidd; Gabriel Hoffman; Noah Zimmerman; Li Li; Joseph W Morgan; Patricia K Glowe; Gregory J Botwin; Samir Parekh; Nikolina Babic; Matthew W Doust; Gregory B Stock; Eric E Schadt; Joel T Dudley
Journal:  J Clin Invest       Date:  2016-03-28       Impact factor: 14.808

8.  Tumour heterogeneity in the clinic.

Authors:  Philippe L Bedard; Aaron R Hansen; Mark J Ratain; Lillian L Siu
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

Review 9.  Competency assessment in the clinical microbiology laboratory.

Authors:  Susan E Sharp; B Laurel Elder
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

10.  Comparative clinical study of canine and feline total blood cell count results with seven in-clinic and two commercial laboratory hematology analyzers.

Authors:  Martina Becker; Andreas Moritz; Urs Giger
Journal:  Vet Clin Pathol       Date:  2008-12       Impact factor: 1.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.